Fate Therapeutics Inc. buy Barclays PLC
Start price
27.02.24
/
50%
€6.42
Target price
27.02.25
€9.22
Performance (%)
-81.86%
End price
28.02.25
€1.16
Summary
This prediction ended on 28.02.25 with a price of €1.16. Massive losses of -81.86% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has a follow-up prediction for Fate Therapeutics Inc. where he still thinks Fate Therapeutics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | 5.623% | 5.623% | 42.691% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by Barclays_PLC for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Barclays PLC from $6.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.86
14.05.25
14.05.25
€1.79
14.05.26
14.05.26
20.88%
31.03.26
31.03.26
